NORTHWEST BIOTHERAPEUTICS INC: cashflow_financing

Value{"amount": 40843000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2024-01-01 – 2024-09-30
Statuscurrent
EntityNORTHWEST BIOTHERAPEUTICS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001410578-24-001879 · Open the official SEC filing →
Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001072379/cashflow-financing/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/db64d35a-7729-47c2-a7d0-e98466b2f5c7

History

From the Record